Pediatric Obesity

7 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Obesity, Overweight

Treatments and conditions

Pediatric Obesity
Treatment and conditionWhere it standsTrials
Oxytocin for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Qsymia and lifestyle management therapy for pediatric obesityTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 Mid Dose for pediatric obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 oral capsule for pediatric obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 Top Dose for pediatric obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.